Press Releases

Optovue Names VP of US Sales

He’s tasked with identifying new partnership opportunities.

Published

5 years ago

January 23, 2019

(PRESS RELEASE) FREMONT, CA – Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), announced the promotion of Joe Garibaldi to vice president of U.S. sales.

In the role, he will continue to lead the U.S. sales force for Optovue as well as identify new strategic partnering opportunities to grow the company’s U.S. product portfolio.

The Best Overall Progressive Lens, Now Powered by AI

Meet the Next Generation of Smart Glasses

Style to Sell!

Sunglass Style Tips: Eyewear Expert Shares What to Wear on National TV

Garibaldi joined Optovue in 2009 as a territory manager and has been promoted into multiple leadership positions within the sales organization, where he has led sales growth in both the optometry and ophthalmology markets. In recent years, he expanded the Optovue sales organization to commercialize the AngioVue OCT Angiography imaging system, which is now the No. 1 selling product at Optovue. Prior to joining Optovue, he was a sales manager for Ophthalmic Instruments and prior to this, he was a recruiter for Apex Systems.

“On behalf of Optovue, it is with great pleasure that I announce the promotion of Joe to this important role for our company,” said Jay Wei, founder and CEO at Optovue. “For the past nine years, Joe has demonstrated excellent sales leadership skills in both the ophthalmic and optometric industries, and he has successfully expanded our sales team to meet the industry demands for the AngioVue OCTA Imaging system and our full product portfolio offering. I have the utmost confidence in Joe’s ability to lead Optovue’s sales team forward.”

Optovue is the first company to develop and commercialize the pioneering OCTA technology, which provides clinicians with information about the blood flow in the retina, the light-sensitive tissue lining the back of the eye.

The company’s proprietary OCTA instrument, the AngioVue System, embodies a non-invasive, dyeless technique for quickly visualizing the presence or absence of flow in the blood vessels, as well as abnormal blood vessels. In seconds, the AngioVue System acquires images to enable physicians to analyze the microvasculature and perfusion in ocular diseases with extraordinary detail, which may help to determine the best course of treatment for each patient.

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width³ according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion⁴ and seamless transitions from near to far.

For more information, visit here.